Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
Del Rio G, Procopio M, Bondi M, Marrama P, Menozzi R, Oleandri SE, Grottoli S, Maccario M, Velardo A, Ghigo E. Del Rio G, et al. Int J Obes Relat Metab Disord. 1997 Dec;21(12):1111-4. doi: 10.1038/sj.ijo.0800523. Int J Obes Relat Metab Disord. 1997. PMID: 9426377 Clinical Trial.
DESIGN: Oral glucose load (OGTT, 100 g p.o. at 0 min) alone and preceded by pyridostigmine (PD, 120 mg p.o., 60 min before OGTT), a cholinesterase inhibitor, were administered on two different occasions, in random order, two or three days apart. ...
DESIGN: Oral glucose load (OGTT, 100 g p.o. at 0 min) alone and preceded by pyridostigmine (PD, 120 mg p.o., 60 min before OGTT), a c …
Alpha-2 adrenergic activity in perimenopausal women.
Del Rio G, Menozzi R, Della Casa L, Venneri MG, Zizzo G, Marrama P, Velardo A. Del Rio G, et al. J Endocrinol Invest. 1997 Nov;20(10):603-10. doi: 10.1007/BF03346917. J Endocrinol Invest. 1997. PMID: 9438918
Effects of galanin and the galanin receptor antagonist galantide on plasma catecholamine levels during a psychosocial stress stimulus in rats.
Ceresini G, Sgoifo A, Freddi M, Musso E, Parmigiani S, Del Rio G, Valenti G. Ceresini G, et al. Neuroendocrinology. 1998 Jan;67(1):67-72. doi: 10.1159/000054300. Neuroendocrinology. 1998. PMID: 9485171
Alpha 2-adrenergic activity is normal in patients with thyroid disease.
Del Rio G, Zizzo G, Marrama P, Venneri MG, Della Casa L, Velardo A. Del Rio G, et al. Clin Endocrinol (Oxf). 1994 Feb;40(2):235-9. doi: 10.1111/j.1365-2265.1994.tb02474.x. Clin Endocrinol (Oxf). 1994. PMID: 8137523
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition.
Del Rio G, Zironi S, Valeriani L, Menozzi R, Bondi M, Bertolini M, Piccinini L, Banzi MC, Federico M. Del Rio G, et al. Breast Cancer Res Treat. 2002 Jun;73(3):267-73. doi: 10.1023/a:1015892714162. Breast Cancer Res Treat. 2002. PMID: 12160332 Clinical Trial.
Adrenomedullary function and its regulation in obesity.
Del Rio G. Del Rio G. Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S89-91. doi: 10.1038/sj.ijo.0801287. Int J Obes Relat Metab Disord. 2000. PMID: 10997618 Review.
The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.
Del Rio G, Carani C, Velardo A, Procopio M, Zizzo G, Savio P, Mantovani R, Marrama P, Ghigo E. Del Rio G, et al. J Endocrinol Invest. 1996 Sep;19(8):505-10. doi: 10.1007/BF03349008. J Endocrinol Invest. 1996. PMID: 8905472 Clinical Trial.
Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.
Del Rio G, Carani C, Velardo A, Zizzo G, Procopio M, Coletta F, Marrama P, Ghigo E. Del Rio G, et al. J Endocrinol Invest. 1995 Oct;18(9):690-5. doi: 10.1007/BF03349790. J Endocrinol Invest. 1995. PMID: 8719299 Clinical Trial.
140 results
Jump to page
Feedback